Identification |
Name: | 5,12-Naphthacenedione,10-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-1,6,8,11-tetrahydroxy-8-(hydroxyacetyl)-,(8S,10S)- (9CI) |
Synonyms: | 5,12-Naphthacenedione,10-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-1,6,8,11-tetrahydroxy-8-(hydroxyacetyl)-,(8S-cis)-; 14-Hydroxycarminomycin |
CAS: | 69401-50-9 |
Molecular Formula: | C26H27 N O11 |
Molecular Weight: | 0 |
InChI: | InChI=1/C26H27NO11/c1-9-21(31)12(27)5-16(37-9)38-14-7-26(36,15(30)8-28)6-11-18(14)25(35)20-19(23(11)33)22(32)10-3-2-4-13(29)17(10)24(20)34/h2-4,9,12,14,16,21,28-29,31,33,35-36H,5-8,27H2,1H3 |
Molecular Structure: |
|
Properties |
Flash Point: | 432.6°C |
Boiling Point: | 791.8°C at 760 mmHg |
Density: | 1.69g/cm3 |
Refractive index: | 1.747 |
Flash Point: | 432.6°C |
Usage: | A semi-synthetic analogue of Carminomycin with cytostatic activity |
Safety Data |
|
|